iVigee

We combine years of operational experience with the latest in AI technologies to deliver a seamless and advanced, client experience. Our culture fosters collaboration, creativity, and the sharing of knowledge with the broader community in the common pursuit of improving drug and patient safety.

Popis
Founded in 2021, all our leaders have years of experience in all areas of pharmacovigilance - science, regulations, and technology. Our acquisition strategy allows us to attract and choose both the best global talent, and companies.
Rok realizace
2024
Obtížnost
Neskutečná
Klient
Skoro normální
Tým
5 x Software Developers, 2 x UX Designers, 1 x Project Manager
Expertise in pharmacovigilance

iVigee is a leading pharmacovigilance services and technology company

While we are proud of our history and expertise, keeping our position as a global thought leader requires the discipline to constantly push forward and innovate, with both services and technology. We are true pioneers in artificial intelligence in PV, and a trusted partner of global companies like Oracle and Deloitte.

Keeping our position

While we are proud of our history and expertise

To provide high added value pharmacovigilance that can reduce the potential harm from medicines. To create an exemplary culture that is appreciated and celebrated by the pharmacovigilance community, our employees, and our clients.

Our network of experts

Strategic centres of excellence in Europe and the US

Our Local QPPVs and Local PV persons are already recruited and contracted, enabling us to deploy a complete local pharmacovigilance service within two months on average, during which we prepare all client-specific documentation and notify local regulatory agencies of the local QPPV or Local PV Person who will be in place.

1000x1000

Acknowledged experts and world leaders

Team has successful track record from leadership positions at Pfizer, BMS, Vertex, Sanofi, and senior ex-regulators from EMA, CHMP, PRAC, and representing EMA at ICH and CIOMS groups. Ex-member of EMA Innovation Taskforce finding the best new regulatory pathways for innovative products.

2000x2000

IT and AI who contribute to, influence, and participate in the developmen

Team has successful track record from leadership positions at Pfizer, BMS, Vertex, Sanofi, and senior ex-regulators from EMA, CHMP, PRAC, and representing EMA at ICH and CIOMS groups. Ex-member of EMA Innovation Taskforce finding the best new regulatory pathways for innovative products.

4000x4000

IT and AI who contribute to, influence, and participate in the developmen

Team has successful track record from leadership positions at Pfizer, BMS, Vertex, Sanofi, and senior ex-regulators from EMA, CHMP, PRAC, and representing EMA at ICH and CIOMS groups. Ex-member of EMA Innovation Taskforce finding the best new regulatory pathways for innovative products.

Team has successful track record from leadership positions at Pfizer, BMS, Vertex, Sanofi, and senior ex-regulators from EMA, CHMP, PRAC, and representing EMA at ICH and CIOMS groups. Ex-member of EMA Innovation Taskforce finding the best new regulatory pathways for innovative products.

Our Local QPPVs and Local PV persons are already recruited and contracted, enabling us to deploy a complete local pharmacovigilance service within two months on average, during which we prepare all client-specific documentation and notify local regulatory agencies of the local QPPV or Local PV Person who will be in place. While we are proud of our history and expertise, keeping our position as a global thought leader requires the discipline to constantly push forward and innovate, with both services and technology. We are true pioneers in artificial intelligence in PV, and a trusted partner of global companies like Oracle and Deloitte.

Source 2000x2000
Source 4000x4000
Source 5000x5000
Source 5000x2500